Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients

Journal of Negative Results in BioMedicine

Volumn 7, Issue 1, 2008, Pages

  Yang, Yun Liang ^a   Cheng, Ming Fang ^b,c   Chang, Ya Wen ^d   Young, Tzuu Guang ^e   Chi, Hsin ^f   Lee, Sai Cheong ^g   Cheung, Bruno Man Hon ^h   Tseng, Fan Chen ^d   Chen, Tun Chieh ⁱ   Ho, Yu Huai ^j   Shi, Zhi Yuan ^k   Chan, Chung Huang Hubert ^g   Lin, Ju Yu ^d   Lo, Hsiu Jung ^d  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e Taipei Municipal Ren Ai Elementary School   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h TAINAN MUNICIPAL HOSPITAL   (Taiwan)

ⁱ KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^j BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^k TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG SENSITIVITY; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TAIWAN; YEAST; ANTIFUNGAL RESISTANCE; CANDIDA; CLASSIFICATION; DRUG EFFECT; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HOSPITALIZATION; HUMANS; TAIWAN;

EID: 58249104010     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-7-12     Document Type: Article

References (24)

1. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. YC Chen SC Chang CC Sun LS Yang WC Hsieh KT Luh, Infect Control Hosp Epidemiol 1997 18 5 369 375 9154483
2. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. MF Cheng KW Yu RB Tang YH Fan YL Yang KS Hsieh M Ho HJ Lo, Diagnostic Microbiology and Infectious Disease 2004 48 1 33 37 10.1016/j.diagmicrobio.2003.08.002
3. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. CC Hung YL Yang TL Lauderdale LC McDonald CF Hsiao HH Cheng YA Ho HJ Lo, Journal of Clinical Microbiology 2005 43 4 1600 1603 15814972 10.1128/JCM.43.4.1600-1603.2005
4. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. H Wisplinghoff T Bischoff SM Tallent H Seifert RP Wenzel MB Edmond, Clin Infect Dis 2004 39 3 309 317 10.1086/421946 15306996
5. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. TC White KA Marr RA Bowden, Clinical Microbiology Reviews 1998 11 2 382 402 9564569
6. Mechanisms of antifungal agent resistance. YL Yang HJ Lo, J Microbiol Immunol Infect 2001 34 2 79 86 11456364
7. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. KA Marr CN Lyons K Ha TR Rustad TC White, Antimicrobial Agents and Chemotherapy 2001 45 1 52 59 10.1128/AAC.45.1.52-59.2001
8. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. MA Pfaller DJ Diekema SA Messer L Boyken RJ Hollis, Journal of Clinical Microbiology 2003 41 4 1440 1446 12682127 10.1128/JCM.41.4.1440-1446. 2003
9. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. YL Yang AH Wang CW Wang WT Cheng SY Li HJ Lo T Hospitals, Diagnostic Microbiology and Infectious Disease 2008 61 2 175 180 10.1016/j.diagmicrobio. 2008.01.011
10. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. YL Yang YA Ho HH Cheng HJ Lo, Epidemiology and Infection 2005 133 2 325 330 10.1017/S0950268804003310
11. In vitro activity of voriconazole against Candida species isolated in Taiwan. YL Yang HH Cheng HJ Lo, International Journal of Antimicrobial Agents 2004 24 3 294 296 10.1016/j.ijantimicag.2004.01.014 15325436
12. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Clinical, Laboratory Standards I, M27A, Wayne, PA 1997
13. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. YL Yang HH Cheng YA Ho CF Hsiao HJ Lo, J Microbiol Immunol Infect 2003 36 3 187 191 14582563
14. Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. YL Yang HH Cheng HJ Lo, Med Mycol 2006 44 3 237 242 10.1080/13693780500401213 16702103
15. Factors accounting for mis-identification of Candida species. HJ Lo AH Ho M Ho, Journal of Microbiology, Immunology, and Infection 2001 34 171 177
16. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. YL Yang YA Ho HH Cheng M Ho HJ Lo, Infection Control and Hospital Epidemiology 2004 25 1 60 64 10.1086/502294
17. Virulence factors of Candida species. YL Yang, J Microbiol Immunol Infect 2003 36 4 223 228 14723249
18. Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. HH Chou HJ Lo KW Chen MH Liao SY Li, Diagnostic Microbiology and Infectious Disease 2007 58 4 427 433 10.1016/j.diagmicrobio.2007.03.014
19. Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. SY Li YL Yang KW Chen HH Cheng CS Chiou TH Wang TL Lauderdale CC Hung HJ Lo, Epidemiology and Infection 2006 134 2 265 269 10.1017/S0950268805004905
20. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. CY Lin YC Chen HJ Lo KW Chen SY Li, Journal of Clinical Microbiology 2007 45 8 2452 2459 17553975 10.1128/JCM.00699-07
21. Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. JS Wang SY Li YL Yang HH Chou HJ Lo, J Med Microbiol 2007 56 Pt 5 650 653 10.1099/jmm.0.46664-0 17446288
22. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients. CM Masia RF Gutierrez D Ortiz de la Tabla AI Hernandez GC Martin SA Sanchez HA Martin, European Journal of Clinical Microbiology and Infectious Diseases 2000 19 8 593 601 10.1007/s100960000323
23. Frequency of Candida sp infection in tuberculous patients with acquired immunodeficiency syndrome: morphological and immunocytochemical study in sputum. MJ Cavaliere MY Maeda FA Longatto NK Shirata RT Santos C Kitamura SY Ueki MC Martins, Pathologica 1994 86 4 409 411 7535911
24. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. AM Sugar XP Liu RJ Chen, Antimicrob Agents Chemother 1997 41 11 2518 2521 9371359